From BIOSCI-REQUEST  Thu Apr  9 05:35:38 1998
Return-Path: BIOSCI-REQUEST
Received: (from daemon@localhost) by net.bio.net (8.6.12-r-beta/8.6.6) id FAA17629; Thu, 9 Apr 1998 05:35:38 -0700
Received: from mailserv.moffitt.usf.edu (root@mailserv.moffitt.usf.edu [131.247.189.20]) by net.bio.net (8.6.12-r-beta/8.6.6) with ESMTP id FAA17626; Thu, 9 Apr 1998 05:35:37 -0700
Received: from rics.moffitt.usf.edu (rics.moffitt.usf.edu [199.76.50.72]) by mailserv.moffitt.usf.edu (8.8.5/8.6.5) with SMTP id MAA23424 for <bioherv@net.bio.net>; Thu, 9 Apr 1998 12:30:44 GMT
Received: from RICS/RICS-PMAIL by rics.moffitt.usf.edu (Mercury 1.12);
    Thu, 9 Apr 98 8:30:14 -500 GMT
Received: from RICS-PMAIL by RICS (Mercury 1.12); Thu, 9 Apr 98 8:30:08 -500 GMT
Received: from 104648.moffitt.usf.edu by rics.moffitt.usf.edu (Mercury 1.12);
    Thu, 9 Apr 98 8:29:45 -500 GMT
Message-ID: <000701bd63b3$7bb50a80$31b0f783@104648.moffitt.usf.edu>
From: "Siamak Tabibzadeh, MD" <tabibzadeh@moffitt.usf.edu>
To: <bioherv@net.bio.net>
Subject: Frontiers in Bioscience, A Journal and Virtual Library
Date: Thu, 9 Apr 1998 08:31:55 -0400
MIME-Version: 1.0
Content-Type: multipart/alternative;
	boundary="----=_NextPart_000_0004_01BD6391.F481D8C0"
X-Priority: 3
X-MSMail-Priority: Normal
X-Mailer: Microsoft Outlook Express 4.72.2106.4
X-MimeOLE: Produced By Microsoft MimeOLE V4.72.2106.4

This is a multi-part message in MIME format.

------=_NextPart_000_0004_01BD6391.F481D8C0
Content-Type: text/plain;
	charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable


             Frontiers in Bioscience

            THE BEST BIOSCIENCE HAS TO OFFER

            Cited by MEDLINE, Index Medicus,=20

            BIOSIS and Chemical Abstracts
            =20
            Frontiers in Bioscience (FBS) is a virtual journal and =
library bringing the most up-to-date data in life sciences and medicine =
to the desktop of every scientist. FBS offers distinct advantages over =
traditional print journals including a rapid review process, free =
world-wide access, electronic reprint, use of multimedia, and links to =
diverse databases including MEDLINE. FBS is read by over 75,000 readers =
internationally and is accessed over 200,000 times every month in the US =
alone. With its mirror sites, over 700 editors and nearly 100 managing =
editors, FBS is truly an international entity and a valuable platform =
for scientific communication. The virtual library provides numerous =
databases, valuable information as well as forms and links to thousands =
of Web sites of interest to researchers and physicians. Visit this =
scientific treasure on the Web.=20
            =20
            Team up with distinguished scientists who contribute to FBS:



                a.. HIV-1 Nef and host cell protein kinases=20

                        Kalle Saksela=20

                        [Vol 2, pp d606-618. December 15, 1997] PubMed =
No: 9388166



                a.. Human immunodeficiency virus type I as a target for =
gene therapy=20
                        Magn=FAs Gottfredsson and Paul R. Bohjanen=20

                        [Vol 2, pp d619-634, December 15, 1997] PubMed =
No: 9388165



                a.. Fibronectin-integrin interactions=20

                        S. Johansson, G. Svineng, K. Wennerberg, A. =
Armulik and L. Lohikangas

                        [Vol 2 pp d126-146, March 1, 1997] PubMed No: =
9159220

            URLs:


            USA: http://www.bioscience.org

            Israel: http://bioinfo.weizmann.ac.il/bioscience

            France: http://vega.crbm.cnrs-mop.fr/bioscience=20


            Frontiers in Bioscience is a non-profit organization =
dedicated to fostering science, education and research
            =20



            =20
            =20




------=_NextPart_000_0004_01BD6391.F481D8C0
Content-Type: text/html;
	charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable

<!DOCTYPE HTML PUBLIC "-//W3C//DTD W3 HTML//EN">
<HTML>
<HEAD>

<META content=3Dtext/html;charset=3Diso-8859-1 =
http-equiv=3DContent-Type>
<META content=3D'"MSHTML 4.72.2106.6"' name=3DGENERATOR>
</HEAD>
<BODY bgColor=3D#ffffff>
<DIV>
<DIV>
<TABLE border=3D1 cellPadding=3D7 cellSpacing=3D4 height=3D975=20
style=3D"HEIGHT: 975px; WIDTH: 569px" width=3D569>
    <TBODY>
    <TR>
        <TD height=3D64 vAlign=3Dtop width=3D20%><FONT size=3D1>
            <P><IMG height=3D57 src=3D"Image1.gif" =
width=3D59></FONT></P></TD>
        <TD height=3D64 vAlign=3Dtop width=3D80%><FONT=20
            face=3D"Old English Text MT,Ribbon131 Bd BT">
            <P align=3Dcenter>Frontiers in Bioscience</P></FONT><B><FONT =
size=3D1>
            <P align=3Dcenter>THE BEST BIOSCIENCE HAS TO =
OFFER</P></FONT><FONT=20
            size=3D1>
            <P align=3Dcenter>Cited by MEDLINE, Index Medicus, </P>
            <P align=3Dcenter>BIOSIS and Chemical =
Abstracts</B></FONT></P></TD></TR>
    <TR>
        <TD colSpan=3D2 height=3D146 vAlign=3Dtop><FONT size=3D1>
            <P align=3Djustify>Frontiers in Bioscience (FBS) is a =
virtual journal=20
            and library bringing the most up-to-date data in life =
sciences and=20
            medicine to the desktop of every scientist. FBS offers =
distinct=20
            advantages over traditional print journals including a rapid =
review=20
            process, free world-wide access, electronic reprint, use of=20
            multimedia, and links to diverse databases including =
MEDLINE. FBS is=20
            read by over 75,000 readers internationally and is accessed =
over=20
            200,000 times every month in the US alone. With its mirror =
sites,=20
            over 700 editors and nearly 100 managing editors, FBS is =
truly an=20
            international entity and a valuable platform for scientific=20
            communication. The virtual library provides numerous =
databases,=20
            valuable information as well as forms and links to thousands =
of Web=20
            sites of interest to researchers and physicians. Visit this=20
            scientific treasure on the Web. </FONT></P></TD></TR>
    <TR>
        <TD colSpan=3D2 height=3D227 vAlign=3Dtop><FONT size=3D1>
            <P align=3Djustify>Team up with distinguished scientists who =

            contribute to FBS:</P></FONT><FONT size=3D1>
            <P align=3Djustify></P>
            <UL><B>
                <P align=3Djustify>
                <LI>HIV-1 Nef and host cell protein kinases=20
                <P></P></LI></UL></B><I>
            <P=20
            =
align=3Djustify>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;=20
            Kalle Saksela </P></I>
            <P=20
            =
align=3Djustify>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;=20
            [Vol 2, pp d606-618. December 15, 1997] PubMed No: =
9388166</P>
            <P align=3Djustify></P>
            <UL><B>
                <P align=3Djustify>
                <LI>Human immunodeficiency virus type I as a target for =
gene=20
                therapy </B></LI></UL><I>
            <P=20
            =
align=3Djustify>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;=20
            Magn&uacute;s Gottfredsson and Paul R. Bohjanen </P></I>
            <P=20
            =
align=3Djustify>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;=20
            [Vol 2, pp d619-634, December 15, 1997] PubMed No: =
9388165</P>
            <P align=3Djustify></P>
            <UL><B>
                <P align=3Djustify>
                <LI>Fibronectin-integrin interactions=20
                <P></P></LI></UL></B><I>
            <P=20
            =
align=3Djustify>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;=20
            S. Johansson, G. Svineng, K. Wennerberg, A. Armulik and L.=20
            Lohikangas</P></I>
            <P=20
            =
align=3Djustify>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;=20
            [Vol 2 pp d126-146, March 1, 1997] PubMed No: 9159220</P>
            <P align=3Djustify>URLs:</P>
            <P align=3Djustify></P>
            <DIR>
            <DIR><B>
            <P>USA:</B> <I>http://www.bioscience.org</P></I><B>
            <P>Israel:=20
</B><I>http://bioinfo.weizmann.ac.il/bioscience</P></I><B>
            <P>France:</B> http://<I>vega.crbm.cnrs-mop.fr/bioscience =
</P>
            <P align=3Dcenter></P></DIR></DIR>
            <P align=3Dcenter>Frontiers in Bioscience is a non-profit =
organization=20
            dedicated to fostering science, education and=20
            research</I></FONT></P></TD></TR></TBODY></TABLE><B><FONT =
size=3D1>
<P></P></B></FONT>
<TABLE border=3D0 cellPadding=3D7 cellSpacing=3D0 width=3D318>
    <TBODY>
    <TR>
        <TD height=3D35 vAlign=3Dtop width=3D6%>
            <P></P></TD>
        <TD height=3D35 vAlign=3Dtop width=3D94%>
            <P></P></TD></TR></TBODY></TABLE><FONT size=3D2>
<P>&nbsp;</P></FONT></DIV></DIV></BODY></HTML>

------=_NextPart_000_0004_01BD6391.F481D8C0--


From BIOSCI-REQUEST  Mon Apr 13 02:00:09 1998
Return-Path: BIOSCI-REQUEST
Received: (from daemon@localhost) by net.bio.net (8.6.12-r-beta/8.6.6) id CAA04423; Mon, 13 Apr 1998 02:00:09 -0700
Received: (from biohelp@localhost) by net.bio.net (8.6.12-r-beta/8.6.6) id CAA04388; Mon, 13 Apr 1998 02:00:06 -0700
Date: Mon, 13 Apr 1998 02:00:06 -0700
From: BIOSCI Administrator <biohelp>
Message-Id: <199804130900.CAA04388@net.bio.net>
To: bioherv@net.bio.net
Subject: BIOSCI/bionet miniFAQ & Fundraiser

(LAST REVISION: 30-JUL-95)

This BIOSCI "miniFAQ" is designed to answer the questions that come up
the *most frequently*.  The main BIOSCI FAQ (Frequently Asked
Questions) is accessible on the World Wide Web at URL
http://www.bio.net/.

If you can not find an answer to your question in this or other
documentation, the BIOSCI technical support staff answers e-mail
queries sent to

		       biosci-help@net.bio.net

We can only answer questions about the use of the newsgroups and
mailing lists.  We unfortunately do not have the staff to do Internet
information searches or answer scientific questions.  Please post
those to the appropriate BIOSCI/bionet newsgroups.


	Contents:
	--------
	0) BIOSCI NEEDS YOUR SUPPORT!!

	1) Using the WWW to access the BIOSCI/bionet newsgroups.

	2) What to do about "spams," i.e., junk mail, ads, etc.

	3) Examples of subscribing and unsubscribing to the mailing lists.

	4) The BIOSCI user address and research interest directory.


0) BIOSCI NEEDS YOUR SUPPORT!!
------------------------------
BIOSCI's government funding has been expended, and we are now
operating solely from advertising revenue that we have raised from our
Web site at http://www.bio.net/.  We need just a few minutes of your
time to help us serve you.

You can do two important things which will take very little time for
you individually and will immensely help us continue to help you.

First, please use our WWW system at http://www.bio.net/ to access the
archives.  You can post or reply to messages via your Web browser as
described in item #1 below.  Your usage helps attract sponsors. If you
contact any of our sponsors, please be sure to thank them for
supporting BIOSCI. It is critical for them to get this feedback if
they are to continue their sponsorship for the long term.

Second, if you work for a company or organization that provides
products or services of interest to the biology community, please pass
this message on to your marketing or marketing communications
department or other appropriate group.  Please ask them to help
support BIOSCI by sponsoring our Web site and explain the uses and
benefits of the system to the biology community. If they are
interested, they can then contact us for further information at our
tech support address, biosci-help@net.bio.net.


1) Using the WWW to access the BIOSCI/bionet newsgroups.
--------------------------------------------------------
As of 10 December 1995, all BIOSCI/bionet full newsgroups are
accessible through the World Wide Web (WWW) at URL http://www.bio.net.
One can read and reply publicly or privately to both recent postings
and archived messages through one's Web browser if it is configured
properly to send e-mail.  Each newsgroup is equipped with its own WAIS
index.  The main BIOSCI home page also has access to the BIO-JOURNALS
Table of Contents database WAIS index and the BIOSCI user address
database described in another item further below.


2) What to do about "spams," i.e., junk mail, ads, etc.
-------------------------------------------------------
BIOSCI is a set of parallel USENET newsgroups (the "bionet" groups),
mailing lists, and a hypermail archive at URL http://www.bio.net/.
The same postings are distributed on all media (except for a small
number of mailing-list-only groups at net.bio.net).  Unfortunately it
is becoming a despicable practice on the Internet (by a few people out
to make a fast buck) to do automated mass postings to thousands of
newsgroups and mailing lists.  These attempts to grab free advertising
are refered to as "spams" in the usual, somewhat boneheaded, net
terminology.  USENET is more susceptible to this practice, and many
spams originate on the USENET groups and then are passed on to the
mailing lists.  However, spammers also get lists of mailing addresses
and hit these too, so neither medium is immune.

What should you do personally if you get junk mail?
---------------------------------------------------
Just delete it and move on without reading it further.  Filing a
protest is becoming increasingly useless because spammers are often
disguising the addresses where the messages are sent from.  Unless you
really understand Internet mail systems, your attempt at protest by
sending replies to the message will often end up being sent to the
address of an innocent person that the spammer is victimizing.

What can BIOSCI/bionet do to protect its newsgroups?
----------------------------------------------------
The only solution currently available is to moderate the newsgroup.
If this newsgroup is already moderated, then you are in good shape.
Moderation protects the USENET distribution from about 95% of the
spams that are being sent to date and protects the mailing lists
completely.  Moderation means, however, that someone has to take the
time to review each message before it goes out.  We have set up
software here that simply allows the moderator to forward to an
address at net.bio.net messages that (s)he wishes to have distributed.
This takes no more time than that needed to read the message and pass
it on, say about 1 min. per message.

Most newsgroups currently have a discussion leader who is responsible
for their newsgroup.  The discussions leaders and their e-mail
addresses are listed in the BIOSCI Information Sheet which is
available on the Web at http://www.bio.net/.  If a newsgroup is being
hit with too many junk postings, please contact the discussion leader
for that group and see if there is interest in moderating the group.
Please do not assume that by simply posting a complaint to the
newsgroup itself, anyone on the BIOSCI staff will act on your
complaint.  With close to 100 newsgroups to run, the BIOSCI staff has
to rely on the discussion leaders of each newsgroup to report problems
directly to us at biosci-help@net.bio.net.

We will moderate any of our newsgroups if the discussion leader tells
us that the readership of the group wishes to do so and if a moderator
is willing to do the work.  For most BIOSCI/bionet groups, this
entails only a few minutes of work each day.

Moderating a newsgroup will resolve probably 95% of the junk postings
on the USENET distribution.  Unfortunately there are easy ways for
determined spammers to override the moderation mechanism on USENET,
but we can protect our e-mail subscribers from unwanted postings if
the newsgroup is moderated.  You can also access our newsgroups over
the WWW at URL http://www.bio.net.  While this Web interface will not
stop spammers from trying to post to the groups, this will give you
yet another way, besides using USENET news, to keep the junk out of
your personal mail files.  For those of you with local USENET news
systems, the Web interface will also give you faster access to new
newsgroups and recent postings.


3) Examples of subscribing and unsubscribing to the mailing lists.
------------------------------------------------------------------
PLEASE NOTE: The BIOSCI management does NOT act on
subscription/unsubscription requests that are posted improperly to the
newsgroups and mailing lists.  People who do this only bother everyone
on the lists to no avail.  Please be sure to follow the proper
procedures below.

Gory details are in the BIOSCI Information sheets on the Web at
http://www.bio.net.  Below we give an example utilizing the
METHODS-AND-REAGENTS list at both of our two BIOSCI sites:

Users in the Americas and Pacific Rim countries who use the BIOSCI
------------------------------------------------------------------
node at computer net.bio.net:
----------------------------

A) Determine the "listname" which is the <=8 character mail address
                                         ^^^^^^^^^^^^^
   for the group.  These can be found in the BIOSCI Info. Sheet.  For
   the METHODS-AND-REAGENTS group the mailing address is
   methods@net.bio.net.  The listname is the portion of the address to
   the left of the @ sign, i.e., "methods".  The listname is used with
   the "subscribe" and "unsubscribe" commands illustrated below.

B) Mail all commands in the body of a mail message addressed to
   biosci-server@net.bio.net.  Do NOT send commands to the newsgroup
   posting addresses!  Leave the Subject: line blank, any text on it
   will be ignored.

C) In the body of your message put one or more of the following
   commands with an "end" command on the last line, e.g.,

   subscribe methods
   unsubscribe methods
   end

   Do NOT put your e-mail address or other text on these lines.  The
   server only allows you to cancel your subscription if the address
   on your mail header matches the address on our mailing list.
   Please ask for help at biosci-help@net.bio.net if your address has
   changed, e.g., if you know you are on the list but the server tells
   you that you are not a member.


Users in Europe, Africa, and Central Asia who use the BIOSCI node at
--------------------------------------------------------------------
computer daresbury.ac.uk (also known as dl.ac.uk):
-------------------------------------------------

To subscribe and unsubscribe to/from the BIOSCI lists, you need to
specify the full USENET newsgroup name with "bionet-news." prepended.
The USENET newsgroup names are listed in the BIOSCI Information sheet
on the Web at http://www.bio.net/.  For the METHODS-AND-REAGENTS list
the USENET newsgroup name is bionet.molbio.methds-reagnts, thus the
appropriate commands are

    sub bionet-news.bionet.molbio.methds-reagnts

    unsub bionet-news.bionet.molbio.methds-reagnts

These commands are included in a message addressed to mxt@dl.ac.uk,
NOT to the newsgroup mailing addresses.  As usual, include the text in
the body of the message as text on the Subject: line is ignored.

To unsubscribe from all the lists at the UK node, use

    unsub bionet-news

Please note that if the address in the list is different than the one
in your mail message header, you will not be able to unsubscribe by
this method. If you have problems, please mail biosci@daresbury.ac.uk.


4) The BIOSCI user address and research interest directory.
-----------------------------------------------------------
Please take this opportunity to add your name, address, and research
interest information to the BIOSCI User Address Database if you have
not already done so.

You can fill out the address form directly through our Web page at URL
http://www.bio.net/adrform.html.

The address database is reindexed nightly for WWW access (the URL is
http://www.bio.net/).  If you are not directly on the Internet but can
reach it by e-mail, please use our waismail server to access the user
directory.  waismail use is described above.  You can also request a
user address form by e-mail from biosci-help@net.bio.net.

Please check your database entry from time-to-time to see if your
address information is still up-to-date.  Because of our limited
personnel resources, we ask that you resubmit a *complete* form to
revise your entry; we only replace complete entries and do not have
resources to edit old forms.


From BIOSCI-REQUEST  Tue Apr 14 12:08:20 1998
Return-Path: BIOSCI-REQUEST
Received: (from daemon@localhost) by net.bio.net (8.6.12-r-beta/8.6.6) id MAA26604; Tue, 14 Apr 1998 12:08:20 -0700
Received: from mail.med.cornell.edu (mail.med.cornell.edu [140.251.2.4]) by net.bio.net (8.6.12-r-beta/8.6.6) with ESMTP id MAA26601; Tue, 14 Apr 1998 12:08:19 -0700
Received: from 140.251.162.200 (mac103750.med.cornell.edu [140.251.162.200]) by mail.med.cornell.edu (8.7.3/8.8.x/cumc1) with SMTP id PAA38668 for <bioherv@net.bio.net>; Tue, 14 Apr 1998 15:06:39 -0400
Message-ID: <3533C398.31C1@mail.med.cornell.edu>
Date: Tue, 14 Apr 1998 15:14:15 -0500
From: gilles marodon <gmarodon@mail.med.cornell.edu>
Reply-To: gmarodon@mail.med.cornell.edu
Organization: Cornell University Medical College
X-Mailer: Mozilla 3.01 (Macintosh; I; PPC)
MIME-Version: 1.0
To: bioherv@net.bio.net
Subject: looks like nobody cares about HERV's
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit

hello, somebody's there?
HERV are not fashionnable yet, but may very well represent the biggest
challenge that immunology wiil have to face in the next century. So
long!

From BIOSCI-REQUEST  Wed Apr 15 02:27:28 1998
Return-Path: BIOSCI-REQUEST
Received: (from daemon@localhost) by net.bio.net (8.6.12-r-beta/8.6.6) id CAA00703; Wed, 15 Apr 1998 02:27:28 -0700
Received: from amcbob.amc.uva.nl (amcbob.amc.uva.nl [145.117.34.37]) by net.bio.net (8.6.12-r-beta/8.6.6) with ESMTP id CAA00692; Wed, 15 Apr 1998 02:27:21 -0700
Received: from l1-105a1.amc.uva.nl by amc.uva.nl (PMDF V5.0-8 #2498)
 id <01IVWAEL8SHS97HCV2@amc.uva.nl> for bioherv@net.bio.net; Wed,
 15 Apr 1998 11:25:23 +0001
Date: Wed, 15 Apr 1998 11:25:18 -0700
From: Ben Berkhout <b.berkhout@AMC.UVA.NL>
Subject: Request for full-length HERV-K construct
To: bioherv@net.bio.net
Reply-to: meibergdreef@AMC.UVA.NL, 15@AMC.UVA.NL, 1105@AMC.UVA.NL,
        AZ@AMC.UVA.NL, Amsterdam@AMC.UVA.NL, the@AMC.UVA.NL,
        Netherlands@AMC.UVA.NL
Message-id: <3534FB8E.148@amc.uva.nl>
Organization: Academic Medical Center
MIME-version: 1.0
X-Mailer: Mozilla 3.0 (Win16; I)
Content-type: text/plain; charset=us-ascii
Content-transfer-encoding: 7bit

Dear HERV researchers,
I would like to include a full-length HERV-K genome in our studies. For
instance, the prototype HERV-K10 isolate as desribed by dr. Ono (J.
Virology, 1986) will be very useful. Perhaps you know who might have
this clone. Any other plasmid that contains most of the HERV-K genome is
welcome too. It would also be very helpful if someone knew the current
address of dr. Ono. Thank you in advance.
dr. Ben Berkhout
b.berkhout@amc.uva.nl

From BIOSCI-REQUEST  Fri Apr 17 06:27:28 1998
Return-Path: BIOSCI-REQUEST
Received: (from daemon@localhost) by net.bio.net (8.6.12-r-beta/8.6.6) id GAA28607; Fri, 17 Apr 1998 06:27:28 -0700
Received: from ssmain.uniss.it (ssmain.uniss.it [193.205.8.2]) by net.bio.net (8.6.12-r-beta/8.6.6) with ESMTP id GAA28584; Fri, 17 Apr 1998 06:26:47 -0700
Received: from neural.uniss.it (neural.fisica.uniss.it [193.205.8.210]) by ssmain.uniss.it with SMTP (8.8.8/8.8.8) id PAA05982 for <bioherv@net.bio.net>; Fri, 17 Apr 1998 15:24:52 +0200 (METDST)
Message-Id: <199804171324.PAA05982@ssmain.uniss.it>
X-Sender: billia@ssmain.uniss.it
X-Mailer: QUALCOMM Windows Eudora Pro Version 4.0 Demo
Date: Fri, 17 Apr 1998 15:22:05 +0200
To: bioherv@net.bio.net
From: Valeria Maida <billia@ssmain.uniss.it>
Subject: NAIMI Congress
Mime-Version: 1.0
Content-Type: text/html; charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable

<html>
<font face=3D"Garamond">It gives us great pleasure to inform you that the
NAIMI Congress will be held in Alghero, on the North West of Sardinia, in
the centre of Mediterranean Sea, this September as a satellite symposium
to the Congress in Coordination Chemistry in Florence. This congress is
specifically aimed at those working in the DNA Polymers field and
promises to be a valuable and stimulating occasion. The opportunity for
experts in the general chemical sector to meet those working on the base
of DNA and RNA in an informal setting should lead to interesting
brainstorming sessions, which will undoubtedly be of great use to both
sides.<br>
Yours,<br>
Prof. M.L.Ganadu=A0 &amp;=A0=A0 Prof. M. Taddei - Dipartimento di Chimica - =
via
Vienna, 2 - 07100 Sassari <br>
<br>
<br>
</font><font face=3D"Academy Engraved LET" size=3D1><b><div align=3D"center"=
>
UNIVERSIT=C0 DEGLI STUDI DI SASSARI<br>
</font></b><font face=3D"Demian Bold LET" size=3D7>NAIMI<br>
</font><font face=3D"Academy Engraved LET" size=3D3><i>Nucleic acids and
their interactions with metal ions<br>
<br>
<br>
</font></i><font face=3D"Garamond"><b>Satellite Symposium of the XXXIII
International Conference<br>
on Coordination Chemistry in Florence<br>
Alghero September 5-7 1998<br>
<br>
</b></div>
The mini symposium is intended for researchers in the Chemistry of
Nucleic Acids and Metal Ions field. The main objective of the symposium
is to bring together scientists interested in the different aspects of
the influence of metal ions on the structure and metabolism of DNA. The
main topics will be DNA Polymers, nucleic metal proteins, zinc fingers
and PNA.<br>
<br>
<b>Scientific Program:<br>
</b>The following distinguished speakers have already agreed to deliver a
lecture: <br>
Prof. James Allan Cowan (<i>COLUMBUS, USA</i>),=A0 <br>
Prof. Rob Kaptein (<i>UTRECHT, THE NETHERLANDS</i>),=A0=A0 <br>
Prof. Bernard Meunier (<i>CNRS, FRANCE</i>),=A0 <br>
Prof. Thomas W. Myers (<i>ROCHE, USA</i>),=A0=A0 <br>
Prof. Huguette Pelletier (<i>HOUSTON, USA</i>).=A0 <br>
Prof. Bibudgendra Sarkar (<i>TORONTO, CANADA</i>),=A0 <br>
In addition there will be a poster session and a number of selected oral
communications. All those who wish to participate are invited to submit
an abstract to the scientific committee.<br>
<br>
<b>Organising committee:<br>
</b>F. Bonomi (University of Milano - Italy) <br>
M.L. Ganadu, Chairperson (University of Sassari - Italy) <br>
H. Kozlowski (University of Wrocklaw - Poland) <br>
C. Mealli (CNR, Florence - Italy) <br>
A. Scozzafava (University of Florence - Italy) <br>
M. Taddei (University of Sassari - Italy) <br>
<br>
additional information and a registration form is available on:<br>
</font><font color=3D"#0000FF"><u><a=
 href=3D"http://www.uniss.it/web/congressi/naimi/naimiaw.htm"=
 eudora=3D"autourl">http://www.uniss.it/web/congressi/naimi/naimiaw.htm</a><=
br>
<br>
</font></u><font color=3D"#000000">For further information, please
contact:<br>
Peter Norton peter.norton@flashnet.it=A0=A0=A0=A0=A0=A0=A0=A0=A0 phone/fax:=
 +39 79
299640<br>
Naimi secretary naimi@ssmain.uniss.it=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=
=A0 fax +39 79 229559 or
229482<br>
Newtours Evangelist@Mail.Newtours-CMO.it=A0=A0=A0=A0=
 Fax+3955/3361250/350<br>
<br>
</font>
<BR>
<div>*********************************************************************</=
div>
<div>Valeria
Maida<x-tab>&nbsp;&nbsp;&nbsp;</x-tab><x-tab>&nbsp;&nbsp;</x-tab><x-tab>&nbs=
p;</x-tab><x-tab>&nbsp;&nbsp;&nbsp;&nbsp;</x-tab>Tel.
+ 39 79 229542/229588&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </div>
<div>Dipartimento di
Chimica<x-tab>&nbsp;</x-tab><x-tab>&nbsp;&nbsp;&nbsp;&nbsp;</x-tab>fax&nbsp;
+ 39 79 229559/229482&nbsp;&nbsp;&nbsp;&nbsp; </div>
<div>via Vienna,
2<x-tab>&nbsp;&nbsp;&nbsp;</x-tab><x-tab>&nbsp;&nbsp;</x-tab><x-tab>&nbsp;</=
x-tab><x-tab>&nbsp;&nbsp;&nbsp;&nbsp;</x-tab>e-mail
billia@ssmain.uniss.it&nbsp;&nbsp;&nbsp; </div>
<div>07100
Sassari<x-tab>&nbsp;&nbsp;&nbsp;</x-tab><x-tab>&nbsp;&nbsp;</x-tab><x-tab>&n=
bsp;</x-tab><x-tab>&nbsp;&nbsp;&nbsp;&nbsp;</x-tab><x-tab>&nbsp;&nbsp;&nbsp;=
</x-tab><x-tab>&nbsp;&nbsp;</x-tab><x-tab>&nbsp;</x-tab><x-tab>&nbsp;&nbsp;&=
nbsp;&nbsp;</x-tab><x-tab>&nbsp;&nbsp;&nbsp;</x-tab><x-tab>&nbsp;&nbsp;</x-t=
ab><x-tab>&nbsp;</x-tab>&nbsp;&nbsp;&nbsp;
</div>
*********************************************************************
</html>

From BIOSCI-REQUEST  Fri Apr 24 22:39:03 1998
Return-Path: BIOSCI-REQUEST
Received: (from daemon@localhost) by net.bio.net (8.6.12-r-beta/8.6.6) id WAA12398; Fri, 24 Apr 1998 22:39:03 -0700
Received: from ethan1223.cml2.com (ethan1223.cml2.COM [209.160.21.245]) by net.bio.net (8.6.12-r-beta/8.6.6) with SMTP id WAA12394; Fri, 24 Apr 1998 22:39:00 -0700
From: chuck9947@yahoo.com
Message-Id: <199804250539.WAA12394@net.bio.net>
Date: Mon, 20 Apr 1998 19:03:16
To: <bioherv@net.bio.net>
Subject: 400 Search Engines For Only $5.75(1)


         ***   $5.75   ***

     Limited Time Special Offer

 For Only $5.75  We Will Submit Your
 Web Site To 400 Of The Net's Hottest
 Search Engines & Directories...(1)


 * Over 90% of Internet Users Use Search 
   Engines To Find Products & Services. If
   You're Not In Them, They Can't Find You.

 * Immediately Increase Your Sites Exposure

 * Get Noticed By Your Prospects


 Note: (1) Visit our web site for details

 http://www.tiffiny.com/sitesubmissions



======================================
We honor any name removal requests.
Please resond to;
TO:	webmaster@tiffiny.com
SUB:	remove
======================================
 
 
 
 
 
 
 
 
 
 
 
 
 

From BIOSCI-REQUEST  Wed Apr 29 20:04:05 1998
Return-Path: BIOSCI-REQUEST
Received: (from daemon@localhost) by net.bio.net (8.6.12-r-beta/8.6.6) id UAA13433; Wed, 29 Apr 1998 20:04:05 -0700
Received: from 166.55.58.102 (usr30-dialup38.mix2.Atlanta.mci.net [166.55.58.102]) by net.bio.net (8.6.12-r-beta/8.6.6) with SMTP id UAA13387
Date: Wed, 29 Apr 1998 20:03:56 -0700
Message-Id: <199804300303.UAA13387@net.bio.net>
From: Dr.Allen@mailexite.com
To: Medical, Professionals
Subject:  Free Allergy Screening!
X-Reply-To:  www.freeyellow.com/members3/algree
Content-Type: text/plain; charset=ISO-8859-1
Content-Transfer-Encoding: 7bit

//////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////
You can now add allergy screening and custom immunotherapy to your practice-
and there are no upfront costs.

Benefits include continuity of care for the patient, excellent desensitization
programming, and significantly increased revenues for your practice.

Complete program includes training, laboratory based allergy screening, and
complete immunotherapy program in injection ready format.  See how "Allergy
Treatment is Made Easy" through the BioSafe, "Is Life Making You Sick" allergy
treatment program.

Register for your free allergy screening kits and complete information
package:

http://www.freeyellow.com/members3/algree



